SUSAN FUNK: Open Payments
NPI 1033114087 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,079 in 21 payments from 10 companies in 2025. Trend: 2023 $1,686 · 2024 $1,582 · 2025 $1,079
Food & beverage: $980Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $354 |
| Syndax Pharmaceuticals, Inc. | 3 | $206 |
| Genmab U.S., Inc. | 1 | $122 |
| Incyte Corporation | 1 | $96 |
| Astellas Pharma US Inc | 5 | $91 |
| Janssen Scientific Affairs, LLC | 1 | $73 |
| ABBVIE INC. | 2 | $52 |
| GlaxoSmithKline, LLC. | 2 | $50 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $16 |
Products named: RYBREVANT, DARZALEX, Epkinly, Niktimvo, Xtandi, Padcev, VENCLEXTA, OJJAARA.
Industry payments across SC — which companies pay providers there.
